The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting
Open accessAbstract
Transdermal drug delivery systems have been around for decades, and current technologies (e.g., patches, ointments, and creams) enhance the skin permeation of low molecular weight, lipophilic drugs that are efficacious at low doses. The objective of current transdermal drug delivery research is to discover ways to enhance skin penetration of larger, hydrophilic drugs and macromolecules for disease treatment and vaccination. Nanocarriers made of lipids, metals, or polymers have been successfully used to increase penetration of drugs or vaccines, control drug release, and target drugs to specific areas of skin in vivo. While more research is needed to identify the safety of nanocarriers, this technology has the potential to expand the use of transdermal routes of administration to a wide array of therapeutics. Here, we review the current state of nanoparticle skin delivery systems with special emphasis on targeting skin diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
Beasley, R. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07302-9 · Cited by 3,389
Titanium dioxide nanoparticles: a review of current toxicological data
Shi, H., Magaye, R., Castranova, V., & Zhao, J. (2013) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-10-15 · Cited by 1,498
The 500 Dalton rule for the skin penetration of chemical compounds and drugs
Bos, J. D., & Meinardi, M. M. H. M. (2000) · Experimental Dermatology · doi:10.1034/j.1600-0625.2000.009003165.x · Cited by 1,465
Mechanisms regulating skin immunity and inflammation
Pasparakis, M., Haase, I., & Nestle, F. O. (2014) · Nature Reviews Immunology · doi:10.1038/nri3646 · Cited by 886
Tight junction defects in patients with atopic dermatitis
De Benedetto, A., Rafaels, N. M., McGirt, L. Y., Ivanov, A. I., Georas, S. N., Cheadle, C., Berger, A. E., Zhang, K., Vidyasagar, S., Yoshida, T., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.018 · Cited by 747
Nomura, I., Goleva, E., Howell, M. D., Hamid, Q. A., Ong, P. Y., Hall, C. F., Darst, M. A., Gao, B., Boguniewicz, M., Travers, J. B., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3262 · Cited by 731
Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects
Brown, M. B., Martin, G. P., Jones, S. A., & Akomeah, F. K. (2006) · Drug Delivery · doi:10.1080/10717540500455975 · Cited by 688
Sandilands, A., Terron-Kwiatkowski, A., Hull, P. R., O'Regan, G. M., Clayton, T. H., Watson, R. M., Carrick, T., Evans, A. T., Liao, H., Zhao, Y., et al. (2007) · Nature Genetics · doi:10.1038/ng2020 · Cited by 662
Th2 Cytokines and Atopic Dermatitis
B. Brandt, E. (2011) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000110 · Cited by 655
Nanopharmaceuticals (part 1): products on the market
Weissig, V., Pettinger, T., & Murdock, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s46900 · Cited by 591
Nanoparticles – An efficient carrier for drug delivery into the hair follicles
Lademann, J., Richter, H., Teichmann, A., Otberg, N., Blume-Peytavi, U., Luengo, J., Weiß, B., Schaefer, U. F., Lehr, C.-M., & Wepf, R. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.019 · Cited by 573
The important role of stratum corneum lipids for the cutaneous barrier function
van Smeden, J., Janssens, M., Gooris, G. S., & Bouwstra, J. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.11.006 · Cited by 549
Recent advances in thermoregulation
Tansey, E. A., & Johnson, C. D. (2015) · Advances in Physiology Education · doi:10.1152/advan.00126.2014 · Cited by 527
Eckhart, L., Lippens, S., Tschachler, E., & Declercq, W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.010 · Cited by 515
Nanoparticles and their interactions with the dermal barrier
Schneider, M., Stracke, F., Hansen, S., & Schaefer, U. F. (2009) · Dermato-Endocrinology · doi:10.4161/derm.1.4.9501 · Cited by 489
Penetration of Metallic Nanoparticles in Human Full-Thickness Skin
Baroli, B., Ennas, M. G., Loffredo, F., Isola, M., Pinna, R., & Arturo López-Quintela, M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700733 · Cited by 464
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A., Koo, J. Y. M., Lebwohl, M., Leonardi, C. L., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.055 · Cited by 460
Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation
Zheng, D., Giljohann, D. A., Chen, D. L., Massich, M. D., Wang, X.-Q., Iordanov, H., Mirkin, C. A., & Paller, A. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118425109 · Cited by 409
Nanoparticles skin absorption: New aspects for a safety profile evaluation
Larese Filon, F., Mauro, M., Adami, G., Bovenzi, M., & Crosera, M. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.05.005 · Cited by 390
Guidelines of care for atopic dermatitis
Hanifin, J. M., Cooper, K. D., Ho, V. C., Kang, S., Krafchik, B. R., Margolis, D. J., Schachner, L. A., Sidbury, R., Whitmore, S. E., Sieck, C. K., et al. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.08.003 · Cited by 387
Contrasting pathogenesis of atopic dermatitis and psoriasis—Part I: Clinical and pathologic concepts
Guttman-Yassky, E., Nograles, K. E., & Krueger, J. G. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.053 · Cited by 384
Dissecting the formation, structure and barrier function of the stratum corneum
Matsui, T., & Amagai, M. (2015) · International Immunology · doi:10.1093/intimm/dxv013 · Cited by 364
Microneedles: A New Frontier in Nanomedicine Delivery
Larrañeta, E., McCrudden, M. T. C., Courtenay, A. J., & Donnelly, R. F. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1885-5 · Cited by 339
Cytokines and the Skin Barrier
Hänel, K., Cornelissen, C., Lüscher, B., & Baron, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14046720 · Cited by 305
In Vivo Skin Penetration of Quantum Dot Nanoparticles in the Murine Model: The Effect of UVR
Mortensen, L. J., Oberdörster, G., Pentland, A. P., & DeLouise, L. A. (2008) · Nano Letters · doi:10.1021/nl801323y · Cited by 302
Self-citationAltered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice
Kawasaki, H., Nagao, K., Kubo, A., Hata, T., Shimizu, A., Mizuno, H., Yamada, T., & Amagai, M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.068 · Cited by 301
Nanocarrier-based topical drug delivery for the treatment of skin diseases
Gupta, M., Agrawal, U., & Vyas, S. P. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.686490 · Cited by 278
Delivering drugs by the transdermal route: review and comment
Tanner, T., & Marks, R. (2008) · Skin Research and Technology · doi:10.1111/j.1600-0846.2008.00316.x · Cited by 267
Economic Burden of Psoriasis in the United States: A Systematic Review
Brezinski, E. A., Dhillon, J. S., & Armstrong, A. W. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.3593 · Cited by 261
Nanomaterials in consumer products: a challenging analytical problem
Contado, C. (2015) · Frontiers in Chemistry · doi:10.3389/fchem.2015.00048 · Cited by 246
Stücker, M., Struk, A., Altmeyer, P., Herde, M., Baumgärtl, H., & Lübbers, D. W. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013067 · Cited by 241
Monteiro-Riviere, N. A., Bristol, D. G., Manning, T. O., Rogers, R. A., & Riviere, J. E. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12505567 · Cited by 231
A sunblock based on bioadhesive nanoparticles
Deng, Y., Ediriwickrema, A., Yang, F., Lewis, J., Girardi, M., & Saltzman, W. M. (2015) · Nature Materials · doi:10.1038/nmat4422 · Cited by 230
Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs
Shah, P. P., Desai, P. R., Patel, A. R., & Singh, M. S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.011 · Cited by 229
Cost of atopic dermatitis and eczema in the United States
Ellis, C. N., Drake, L. A., Prendergast, M. M., Abramovits, W., Boguniewicz, M., Daniel, C. R., Lebwohl, M., Stevens, S. R., Whitaker-Worth, D. L., Cheng, J. W., et al. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120528 · Cited by 211
Raza, K., Singh, B., Lohan, S., Sharma, G., Negi, P., Yachha, Y., & Katare, O. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.08.019 · Cited by 208
Objective assessment of nanoparticle disposition in mammalian skin after topical exposure
Campbell, C. S. J., Contreras-Rojas, L. R., Delgado-Charro, M. B., & Guy, R. H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.024 · Cited by 194
Lapteva, M., Mondon, K., Möller, M., Gurny, R., & Kalia, Y. N. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400639e · Cited by 194
Human skin dendritic cells in health and disease
Haniffa, M., Gunawan, M., & Jardine, L. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.08.012 · Cited by 187
Hair Follicles – An Efficient Storage and Penetration Pathway for Topically Applied Substances
Lademann, J., Knorr, F., Richter, H., Blume-Peytavi, U., Vogt, A., Antoniou, C., Sterry, W., & Patzelt, A. (2008) · Skin Pharmacology and Physiology · doi:10.1159/000131079 · Cited by 186
Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin
Ridolfi, D. M., Marcato, P. D., Justo, G. Z., Cordi, L., Machado, D., & Durán, N. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.11.051 · Cited by 183
Human Melanocyte Biology, Toxicology, and Pathology
Tolleson, W. H. (2005) · Journal of Environmental Science and Health Part C · doi:10.1080/10590500500234970 · Cited by 182
Czarnowicki, T., Krueger, J. G., & Guttman-Yassky, E. (2014) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2014.03.006 · Cited by 179
Human skin penetration of gold nanoparticles through intact and damaged skin
Larese Filon, F., Crosera, M., Adami, G., Bovenzi, M., Rossi, F., & Maina, G. (2011) · Nanotoxicology · doi:10.3109/17435390.2010.551428 · Cited by 173
Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016
Saeki, H., Nakahara, T., Tanaka, A., Kabashima, K., Sugaya, M., Murota, H., Ebihara, T., Kataoka, Y., Aihara, M., Etoh, T., et al. (2016) · The Journal of Dermatology · doi:10.1111/1346-8138.13392 · Cited by 172
Drug delivery to hair follicles
Patzelt, A., & Lademann, J. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.776038 · Cited by 170
Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses
Clausen, B. E., & Stoitzner, P. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00534 · Cited by 170
Prevalence of Psoriasis Among Adults in the U.S.
Helmick, C. G., Lee-Han, H., Hirsch, S. C., Baird, T. L., & Bartlett, C. L. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.02.012 · Cited by 168
Eczema, atopy and allergen exposure in adults: a population‐based study
Harrop, J., Chinn, S., Verlato, G., Olivieri, M., Norbäck, D., Wjst, M., Janson, C., Zock, J. ‐., Leynaert, B., Gislason, D., et al. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02679.x · Cited by 162
Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery
Fang, J. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s9155 · Cited by 159
Ilves, M., Palomäki, J., Vippola, M., Lehto, M., Savolainen, K., Savinko, T., & Alenius, H. T. (2014) · Particle and Fibre Toxicology · doi:10.1186/s12989-014-0038-4 · Cited by 156
Interactions of Skin with Gold Nanoparticles of Different Surface Charge, Shape, and Functionality
Fernandes, R., Smyth, N. R., Muskens, O. L., Nitti, S., Heuer‐Jungemann, A., Ardern‐Jones, M. R., & Kanaras, A. G. (2014) · Small · doi:10.1002/smll.201401913 · Cited by 156
Sack, M., Alili, L., Karaman, E., Das, S., Gupta, A., Seal, S., & Brenneisen, P. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0950 · Cited by 154
Adib, Z. M., Ghanbarzadeh, S., Kouhsoltani, M., Khosroushahi, A. Y., & Hamishehkar, H. (2016) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2016.06 · Cited by 153
Carriers in the Topical Treatment of Skin Disease
Körting, H. C., & Schäfer‐Korting, M. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_15 · Cited by 146
Ourique, A. F., Pohlmann, A. R., Guterres, S. S., & Beck, R. C. R. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.035 · Cited by 145
Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin
Manconi, M., Sinico, C., Caddeo, C., Vila, A. O., Valenti, D., & Fadda, A. M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.03.068 · Cited by 145
Bessar, H. A., Venditti, I., Benassi, L., Vaschieri, C., Azzoni, P., Pellacani, G., Magnoni, C., Botti, E., Casagrande, V., Federici, M., et al. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.01.021 · Cited by 141
Xiao, L., Takada, H., Gan, X. H., & Miwa, N. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.12.011 · Cited by 137
Salmon, J. K., Armstrong, C. A., & Ansel, J. C. (1994) · PubMed Central · Cited by 136
Ourique, A. F., Melero, A., Silva, C. D. B. D., Schaefer, U. F., Pohlmann, A. R., Guterres, S. S., Lehr, C.-M., Kostka, K.-H., & Beck, R. C. R. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.03.008 · Cited by 132
In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin
Jensen, L. B., Petersson, K., & Nielsen, H. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.05.012 · Cited by 128
Amano, S. (2016) · Experimental Dermatology · doi:10.1111/exd.13085 · Cited by 127
The Role of Cytokines/Chemokines in the Pathogenesis of Atopic Dermatitis
Yamanaka, K., & Mizutani, H. (2011) · Current problems in dermatology · doi:10.1159/000323299 · Cited by 126
Nanoparticle interaction with the immune system / Interakcije nanodelcev z imunskim sistemom
Kononenko, V., Narat, M., & Drobne, D. (2015) · Archives of Industrial Hygiene and Toxicology · doi:10.1515/aiht-2015-66-2582 · Cited by 126
[CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2018].
Ebihara, T. (2021) · PubMed · doi:10.15036/arerugi.70.1186 · Cited by 119
Immunosuppressive and anti‐inflammatory properties of engineered nanomaterials
Ilinskaya, A. N., & Dobrovolskaia, M. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12722 · Cited by 118
SKIN ANATOMY, PHYSIOLOGY, AND PATHOPHYSIOLOGY
Wysocki, A. B. (1999) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02423-9 · Cited by 115
The Genetics of Psoriasis and Psoriatic Arthritis
Chandran, V. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8303-5 · Cited by 114
Tight junctions and tight junction proteins in mammalian epidermis
Brandner, J. M. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.007 · Cited by 108
van Drongelen, V., Haisma, E. M., Out‐Luiting, J. J., Nibbering, P. H., & Ghalbzouri, A. E. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12443 · Cited by 100
Zhu, Y., Choe, C., Ahlberg, S., Meinke, M. C., Alexiev, U., Lademann, J. M., & Darvin, M. E. (2014) · Journal of Biomedical Optics · doi:10.1117/1.jbo.20.5.051006 · Cited by 98
Anti-inflammatory effect of fullerene C60 in a mice model of atopic dermatitis
Shershakova, N. N., Baraboshkina, E. N., Михайлович, А. С., Purgina, D., Struchkova, I., Kamyshnikov, O., Nikonova, A. A., & Khaitov, M. R. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0159-z · Cited by 95
Alnasif, N., Zoschke, C., Fleige, E., Brodwolf, R., Boreham, A., Rühl, E., Eckl, K., Merk, H., Hennies, H. C., Alexiev, U., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.006 · Cited by 93
Nanoparticles Do Not Penetrate Human Skin—A Theoretical Perspective
Watkinson, A. C., Bunge, A. L., Hadgraft, J., & Lane, M. E. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1073-9 · Cited by 92
Marchiori, M., Lubini, G., Nora, G. D., Friedrich, R. B., Fontana, M. C., Ourique, A. F., Bastos, M. O., Rigo, L. A., da Silva, C. B., Tedesco, S. B., et al. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639041003598960 · Cited by 92
Jinnestål, C. L., Belfrage, E., Bäck, O., Schmidtchen, A., & Sonesson, A. (2013) · International Journal of Dermatology · doi:10.1111/ijd.12198 · Cited by 90
Ultrasound-Enhanced Transdermal Delivery: Recent Advances and Future Challenges
Oberli, M. A., Schoellhammer, C. M., Langer, R., & Blankschtein, D. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.32 · Cited by 90
Fontana, M. C., Rezer, J. F. P., Coradini, K., Leal, D. B. R., & Beck, R. C. R. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.05.002 · Cited by 88
Nanocarrier for the Transdermal Delivery of an Antiparkinsonian Drug
Azeem, A., Ahmad, F. J., Khar, R. K., & Talegaonkar, S. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9306-2 · Cited by 87
Microbiota in Healthy Skin and in Atopic Eczema
Baviera, G., Leoni, M. C., Capra, L., Cipriani, F., Longo, G., Maiello, N., Ricci, G., & Galli, E. (2014) · BioMed Research International · doi:10.1155/2014/436921 · Cited by 86
Risk of depression in women with psoriasis: a cohort study
Dommasch, E. D., Li, T., Okereke, O. I., Li, Y., Qureshi, A. A., & Cho, E. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14032 · Cited by 84
Dermal Contributions to Human Interfollicular Epidermal Architecture and Self-Renewal
Lawlor, K. T., & Kaur, P. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226078 · Cited by 84
Silva, C. O., Rijo, P. M., Molpeceres, J., Figueiredo, I. V., Ascensão, L., Fernandes, A. S., Roberto, A., & Reis, C. P. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.044 · Cited by 80
Dermal targeting of tacrolimus using colloidal carrier systems
Goebel, A. S. B., Neubert, R. H. H., & Wohlrab, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.11.029 · Cited by 77
Surface-Charge-Dependent Nanoparticles Accumulation in Inflamed Skin
Abdel-Mottaleb, M. M. A., Moulari, B., Béduneau, A., Pellequer, Y., & Lamprecht, A. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23282 · Cited by 75
Abnormal epidermal barrier in the pathogenesis of psoriasis
Wolf, R., Orion, E., Ruocco, E., & Ruocco, V. (2012) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.08.022 · Cited by 72
Desmet, E., Bracke, S., Forier, K., Taevernier, L., Stuart, M. C. A., Spiegeleer, B. M. J. D., Raemdonck, K., Gele, M. V., & Lambert, J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.042 · Cited by 72
Miquel‐Jeanjean, C., Crépel, F., Raufast, V., Payré, B., Datas, L., Bessou‐Touya, S., & Duplan, H. (2012) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2012.01181.x · Cited by 70
Siddique, M. I., Katas, H., Amin, M. C. I. M., Ng, S., Zulfakar, M. H., & Jamil, A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.05.005 · Cited by 70
Nanoparticles for transcutaneous vaccination
Hansen, S., & Lehr, C. (2011) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2011.00284.x · Cited by 69
Pathogenesis of Psoriasis: Current Concepts
Kadunce, D. P., & Krueger, G. G. (1995) · Dermatologic Clinics · doi:10.1016/s0733-8635(18)30037-8 · Cited by 66
Effective topical delivery systems for corticosteroids: dermatological and histological evaluations
Eroğlu, İ., Azizoğlu, E., Özyazıcı, M., Nenni, M., Gürer-Orhan, H., Özbal, S., Tekmen, I., Ertam, İ., Ünal, İ., & Ozer, Ö. (2014) · Drug Delivery · doi:10.3109/10717544.2014.960981 · Cited by 66
Influence of surface charge of gold nanorods on skin penetration
Lee, O., Jeong, S. H., Shin, W. U., Lee, G., Oh, C. H., & Son, S. W. (2012) · Skin Research and Technology · doi:10.1111/j.1600-0846.2012.00656.x · Cited by 65
Early allergen exposure and atopic eczema
Harris, J. M., Williams, H. C., White, C., Moffat, S., Mills, P., Taylor, A. J. N., & Cullinan, P. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07710.x · Cited by 64
Psoriasis is not an autoimmune disease?
Fry, L., Baker, B. S., Powles, A. V., & Engstrand, L. G. (2014) · Experimental Dermatology · doi:10.1111/exd.12572 · Cited by 62
D’Souza, L. S., & Payette, M. J. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.11.028 · Cited by 61
Pople, P. V., & Singh, K. K. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.11.026 · Cited by 60
Depieri, L. V., Borgheti-Cardoso, L. N., Campos, P. M., Otaguiri, K. K., Vicentini, F. T. M. C., Lopes, L. B., Fonseca, M. J. V., & Bentley, M. V. L. B. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.05.012 · Cited by 59
Dreier, J., Sørensen, J. A., & Brewer, J. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146514 · Cited by 57
Bracke, S., Carretero, M., Guerrero‐Aspizua, S., Desmet, E., Illera, N., Navarro, M., Lambert, J., & Río, M. D. (2014) · Experimental Dermatology · doi:10.1111/exd.12321 · Cited by 54
Advanced microscopy of star-shaped gold nanoparticles and their adsorption-uptake by macrophages
Plascencia‐Villa, G., Bahena, D., Rodriguez, A. R., Ponce, A., & José–Yacamán, M. (2013) · Metallomics · doi:10.1039/c3mt20202j · Cited by 51
Jung, S.-M., Yoon, G. H., Lee, H. C., et al. (2015) · Scientific Reports · doi:10.1038/srep18089 · Cited by 50
Prevention of experimental motion sickness by scopolamine absorbed through the skin.
Graybiel, A., Knepton, J. C., & Shaw, J. E. (1976) · PubMed · Cited by 49
A new concept for the treatment of atopic dermatitis: Silver–nanolipid complex (sNLC)
Keck, C. M., Anantaworasakul, P., Patel, M., Okonogi, S., Singh, K. K., Roessner, D., Scherrers, R., Schwabe, K., Rimpler, C., & Müller, R. H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.12.044 · Cited by 44
In vivo skin penetration and metabolic path of quantum dots
Tang, L., Zhang, C., Song, G., Jin, X., & Xu, Z. (2013) · Science China Life Sciences · doi:10.1007/s11427-012-4404-x · Cited by 35
Filaggrin‐2 barrier protein inversely varies with skin inflammation
Seykora, J. T., Dentchev, T., & Margolis, D. J. (2015) · Experimental Dermatology · doi:10.1111/exd.12749 · Cited by 34
Dermal absorption of amorphous nanosilica particles after topical exposure for three days
Hirai, T., Yoshikaw, T., Nabeshi, H., Yoshid, T., Akase, T., Yoshioka, Y., Itoh, N., & Tsutsumi, Y. (2012) · Die Pharmazie · doi:10.31083/ph.2012.1853 · Cited by 32
Kanazawa, T., Hamasaki, T., Endo, T., Tamano, K., Sogabe, K., Seta, Y., Ohgi, T., & Okada, H. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.05.003 · Cited by 32
Barrier repair in chronic plaque‐type psoriasis
Goon, A., Yosipovitch, G., Chan, Y., & Goh, C. (2004) · Skin Research and Technology · doi:10.1111/j.1600-0846.2004.00046.x · Cited by 31
Quantification of quantum dot murine skin penetration with UVR barrier impairment
Mortensen, L. J., Jatana, S., Gelein, R. M., Benedetto, A. D., Bentley, K. L. D. M., Beck, L. A., Elder, A. C. P., & DeLouise, L. A. (2012) · Nanotoxicology · doi:10.3109/17435390.2012.741726 · Cited by 30
Self-citationLoss-of-Function Mutations within the Filaggrin Gene and Atopic Dermatitis
Kawasaki, H., Kubo, A., Sasaki, T., & Amagai, M. (2011) · Current problems in dermatology · doi:10.1159/000323291 · Cited by 29
Heterogeneous Drying Stresses in Stratum Corneum
German, G. K., Engl, W., Pashkovski, E. E., Banerjee, S., Xu, Y., Mertz, A. F., Hyland, C., & Dufresne, E. R. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.04.045 · Cited by 29
Penetration of Titanium Dioxide Nanoparticles through Slightly Damaged Skin in Vitro and in vivo
Xie, G., Lu, W., & Dong-min, L. (2015) · Journal of Applied Biomaterials & Functional Materials · doi:10.5301/jabfm.5000243 · Cited by 28
Transdermal Drug Delivery System: Patent Reviews
Samad, A., Ullah, Z., Alam, M. I., Wais, M., & Shams, M. (2009) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221109788452294 · Cited by 25
What's new in the topical treatment of allergic skin diseases
Aslam, I., Sandoval, L. F., & Feldman, S. R. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000093 · Cited by 11
Quoi de neuf en thérapeutique dermatologique ?
Martin, L. (2010) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(10)70043-0 · Cited by 1
Cited by
The emerging role of nanotechnology in skincare
Salvioni, L., Morelli, L., Ochoa, E., Labra, M., Fiandra, L., Palugan, L., Prosperi, D., & Colombo, M. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102437 · Cited by 317
Metadata
- Authors
- Palmer, B., & DeLouise, L.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2016-12-15
- Volume
- 21
- Issue
- 12
- Pages
- 1719
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2564076115
- Cited by
- 267
- References
- 119
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.